RAPS Convergence program and speakers are subject to change.
Session Leader/Speaker: Sabine Haubenreisser, MSc, PhD – European Medicines Agency
Speaker: Anabela Marcal – European Medicines Agency
Speaker: Karl-Heinz Huemer, MD, PhD – AGES (Austrian Agency for Health & Food Safety)
Speaker (Remote): Ana Hidalgo-Simon, MD, PhD – European Medicines Agency
Speaker (Remote): Falk Ehmann, MD, PhD, MSc, – European Medicines Agency
Speaker (Remote): Jeffrey Shuren, MD, JD – United States Food and Drug Administration
Speaker (Remote): Barbara Zimmerman
Speaker: Doug Kelly, MD – U.S. Food and Drug Administration
Speaker (Remote): Daniel CaƱos, PhD, MPH – US Food and Drug Administration
Speaker (Remote): Michelle Tarver, MD, PhD – U.S. Food and Drug Administration
Speaker (Remote): Eli Tomar, JD, MPH – US Food and Drug Administration
Moderator: Megha Deviprasad Iyer, MS, RAC – Thermo Fisher Scientific
Speaker (Remote): Bruce Randall, B. Sc – Health Canada
Moderator: Linda McBride, R.Ph., RAC – IAA Consulting LLC
Speaker: David Boudreau, ing – Health Canada
Speaker (Remote): Peter W. Marks, MD, PhD – United States Food and Drug Administration
Speaker (Remote): Christopher Joneckis, PhD – US FDA
Moderator: Sonday L. Kelly, MS, RAC, PMP – Regulatory Project Management Staff / Office of Blood Research and Review / Center for Biologics Evaluation and Research / Food and Drug Administration
Speaker (Remote): Peter P. Stein, MD – Office of New Drugs, CDER, FDA
Moderator: David Chadwick, PhD, RAC, FRAPS – Cook Medical
Speaker: Kuniki Imagawa, MSc – PMDA
Speaker: Haruko Yamamoto, MD, PhD – Pharmaceuticals and Medical Devices Agency